<mods xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.loc.gov/mods/v3" version="3.3" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-3.xsd" ID="P0b002ee18fd48aa6">
<name type="corporate">
 <namePart>United States Government Publishing Office</namePart>
 <role>
  <roleTerm authority="marcrelator" type="text">publisher</roleTerm>
  <roleTerm authority="marcrelator" type="code">pbl</roleTerm>
</role>
 <role>
  <roleTerm authority="marcrelator" type="text">distributor</roleTerm>
  <roleTerm authority="marcrelator" type="code">dst</roleTerm>
</role>
</name>
<name type="corporate">
 <namePart>United States</namePart>
 <namePart>Government Accountability Office</namePart>
 <role>
  <roleTerm authority="marcrelator" type="text">author</roleTerm>
  <roleTerm authority="marcrelator" type="code">aut</roleTerm>
</role>
 <description>Government Organization</description>
</name>
<typeOfResource>text</typeOfResource>
<genre authority="marcgt">government publication</genre>
<language>
 <languageTerm type="code" authority="iso639-2b">eng</languageTerm>
</language>
<extension>
 <collectionCode>GAOREPORTS</collectionCode>
 <category>Legislative Agency Publications</category>
 <waisDatabaseName>gao_comptroller_general</waisDatabaseName>
 <branch>legislative</branch>
 <dateIngested>2016-06-23</dateIngested>
</extension>
<originInfo>
 <publisher>U.S. Government Publishing Office</publisher>
 <dateIssued encoding="w3cdtf">2004-01-09</dateIssued>
 <issuance>monographic</issuance>
</originInfo>
<physicalDescription>
 <note type="source content type">deposited</note>
 <digitalOrigin>born digital</digitalOrigin>
 <extent>49 p.</extent>
</physicalDescription>
<classification authority="sudocs">GA 1.13:B-292981</classification>
<identifier type="uri">https://www.govinfo.gov/app/details/GAOREPORTS-B-292981</identifier>
<identifier type="local">P0b002ee18fd48aa6</identifier>
<identifier type="former package identifier">f:292981</identifier>
<recordInfo>
 <recordContentSource authority="marcorg">DGPO</recordContentSource>
 <recordCreationDate encoding="w3cdtf">2016-06-23</recordCreationDate>
 <recordChangeDate encoding="w3cdtf">2016-06-23</recordChangeDate>
 <recordIdentifier source="DGPO">GAOREPORTS-B-292981</recordIdentifier>
 <recordOrigin>machine generated</recordOrigin>
 <languageOfCataloging>
  <languageTerm type="code" authority="iso639-2b">eng</languageTerm>
</languageOfCataloging>
</recordInfo>
<accessCondition type="GPO scope determination">fdlp</accessCondition>
<extension>
 <docClass>COMPTROLLERDECISION</docClass>
 <accessId>GAOREPORTS-B-292981</accessId>
 <reportNumber>B-292981</reportNumber>
 <type>Comptroller General Decision</type>
</extension>
<titleInfo>
 <title>ACS State Healthcare, LLC; PharmaCare Government Services, Inc.; PGBA, LLC; Humana Military Healthcare Services, Inc., B-292981; B-292981.2; B-292981.3; B-292981.4; B-292981.5; B-292981.6; B-292981.7; B-292981.8; B-292981.9 B-292981.10, January 9, 2004</title>
</titleInfo>
<abstract>1.  In negotiated procurement under which the contractor will acquire
pharmaceuticals for Department of Defense (DoD) using DoD funds, and where
solicitation requests offerors to propose discount rates and dispensing
fees for pharmaceuticals in addition to their fixed prices, and provides
for evaluation of government*s projected future costs for pharmaceuticals
(*Total Expected Government Cost* (TEGC)) as a technical factor, agency
reasonably assessed likelihood that offerors could provide pharmaceuticals
at their proposed discount rates and dispensing fees; cost realism
analysis of offerors* TEGCs was not required, where solicitation did not
require such an analysis.
    
2.  Source selection authority (SSA) performed reasonable cost/technical
tradeoff in determining the awardee*s proposal for supporting
pharmaceutical program represented best value, where the SSA*s judgment,
based upon the results of a reasonable, well-documented technical
evaluation, is set forth in a detailed decision document that demonstrates
the SSA*s understanding of the evaluated strengths and weaknesses of the
respective proposals, and that shows a reasonable weighing of the
offerors* respective technical and price advantages consistent with the
solicitation*s evaluation criteria.</abstract>
<location>
 <url displayLabel="HTML rendition" access="raw object">https://www.govinfo.gov/content/pkg/GAOREPORTS-B-292981/html/GAOREPORTS-B-292981.htm</url>
 <url displayLabel="PDF rendition" access="raw object">https://www.govinfo.gov/content/pkg/GAOREPORTS-B-292981/pdf/GAOREPORTS-B-292981.pdf</url>
</location>
<identifier type="preferred citation">GAO/B-292981</identifier>
<location>
 <url displayLabel="Content Detail" access="object in context">https://www.govinfo.gov/app/details/GAOREPORTS-B-292981</url>
</location>
<note>Comptroller General Decision</note>
<extension>
 <searchTitle>GAO/B-292981; ACS State Healthcare, LLC; PharmaCare Government Services, Inc.; PGBA, LLC; Humana Military Healthcare Services, Inc., B-292981; B-292981.2; B-292981.3; B-292981.4; B-292981.5; B-292981.6; B-292981.7; B-292981.8; B-292981.9 B-292981.10, January 9, 2004;
            </searchTitle>
</extension>
</mods>